Latest evidence update: 2013-02-09
Strongest in Study quality (70). Held back by Recency (44).
Solid mix of RCTs with some methodological gaps.
Good cross-study replication, some imprecision.
Thousands of participants across the literature.
Mostly aligned, with some divergence.
Evidence base skews older; field may have moved on.
No quantified outcomes yet. Once we have studies with measurable endpoints, you will see per-outcome magnitude here.
Areas where research points to a consistent direction of effect. The strength of evidence is graded; the size of the effect is not quantified.
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.
Palmitoylethanolamide (PEA) supplementation reduces overall autism severity by improving language and social and nonsocial behaviors in individuals with autism spectrum disorder.
Soy or pea protein demonstrated improvements in subjective recovery outcomes and reductions in muscle damage biomarkers following resistance exercise.
Well-formulated plant protein blends (combinations of pea, rice, and canola) stimulate muscle protein synthesis at levels comparable to whey when consumed at adequate doses (≥30 g with ~2.5 g leucine).
Nasal spray corticosteroids were more effective than palmitoylethanolamide (PEA) supplementation in reducing COVID-19-related olfactory dysfunction duration.
Digestibility of protein blends containing different ratios of animal and plant proteins (casein/soy, whey/casein/soy/pea, casein/whey) showed no significant differences in older men.